Tag: Company Report

May, 10, 2014 : Company Profiles and Conferences presents a Company Report on “Intellipharmaceutics International Inc. (IPCI) – Financial and Strategic SWOT Analysis Review”, which helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Summary
This comprehensive SWOT profile of Intellipharmaceutics International Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile is bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms is the part of Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Intellipharmaceutics International Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including,

– Business description A detailed description of the companys operations and business divisions.
– Corporate strategy Analysts summarization of the companys business strategy.
– SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
– Company history Progression of key events associated with the company.
– Major products and services A list of major products, services and brands of the company.
– Key competitors A list of key competitors to the company.
– Key employees A list of the key executives of the company.
– Executive biographies A brief summary of the executives employment history.
– Key operational heads A list of personnel heading key departments/functions.
– Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the companys business structure, operations, major products and services.

July, 14, 2014 : Company Profiles and Conferences presents a Company Report on “Gentiva Health Services, Inc. (GTIV) – Financial and Strategic SWOT Analysis Review”, who helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Gentiva Health Services, Inc. (GTIV) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile is bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description A detailed description of the companys operations and business divisions.
– Corporate strategy Analysts summarization of the companys business strategy.
– SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
– Company history Progression of key events associated with the company.
– Major products and services A list of major products, services and brands of the company.
– Key competitors A list of key competitors to the company.
– Key employees A list of the key executives of the company.
– Executive biographies A brief summary of the executives employment history.
– Key operational heads A list of personnel heading key departments/functions.
– Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Gentiva Health Services, Inc. (Gentiva) is a provider of home health and hospice services. It offers various healthcare services through its two reportable segments, namely, Home Health, Hospice and Community Care. The company provides various patient care services at the patients home or hospital. It specializes in providing services including skilled nursing; physical, occupational, speech and neuro-rehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; and other therapies and services. The company delivers its services directly to patients through more than 550 locations in 40 states in the US.

July, 25, 2014: Company Profiles and Conferences presents a Company Report on “Xcite Energy Limited (XEL) – Financial and Strategic SWOT Analysis Review”, who helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Xcite Energy Limited (XEL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile is bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description A detailed description of the companys operations and business divisions.
– Corporate strategy Analysts summarization of the companys business strategy.
– SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
– Company history Progression of key events associated with the company.
– Major products and services A list of major products, services and brands of the company.
– Key competitors A list of key competitors to the company.
– Key employees A list of the key executives of the company.
– Executive biographies A brief summary of the executives employment history.
– Key operational heads A list of personnel heading key departments/functions.
– Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
– Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Xcite Energy Limited (Xcite Energy) is a heavy oil appraisal and development company. It carries out its operations through its wholly owned subsidiary, Xcite Energy Resources Limited (XER). The company holds interest in six blocks through XER. XER holds 100% working interests in the Bentley field in Block 9/3b in the UK North Sea. It is focused on evaluation and development of heavy oil discoveries in the Bentley field. The company also plans to participate in potential acquisitions in order to grow as a significant independent heavy oil producer in the North Sea.

Xcite Energy Limited Key Recent Developments

May 08, 2014 Xcite Energy Announces Board Appointments
May 08, 2014 Xcite Energy Board Appointments
Apr 14, 2014 Xcite Energy Equity Line Facility Agreement Extension
Apr 09, 2014 Xcite Energy MOU With AMEC and ARUP

Aug, 2, 2014 : Company Profiles and Conferences presents a Company Report on “Chemical Company of Malaysia Berhad (CCM) – Financial and Strategic SWOT Analysis Review”, which helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Chemical Company of Malaysia Berhad (CCM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile is bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description A detailed description of the companys operations and business divisions.
– Corporate strategy Analysts summarization of the companys business strategy.
– SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
– Company history Progression of key events associated with the company.
– Major products and services A list of major products, services and brands of the company.
– Key competitors A list of key competitors to the company.
– Key employees A list of the key executives of the company.
– Executive biographies A brief summary of the executives employment history.
– Key operational heads A list of personnel heading key departments/functions.
– Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Chemical Company of Malaysia Berhad (CCM) is a holding company. It offers products and services to chemical, healthcare and agricultural industries. The companys business activities include chemical products and applications; fertilizers and technical advisory services; and pharmaceuticals and healthcare products and services. It offers chemical products such as calcium chloride, caustic soda flake, caustic soda liquor, caustic soda micropearl, alkalinity booster, aluminium sulphate, biocides, caustic soda liquor, and diammonium phosphate. CCMs fertilizers include Loong Choong Pau Red, Loong Choong Pau Green, and CHB NO.45.

Chemical Company of Malaysia Berhad Key Recent Developments

Jun 26, 2013: CCM Banks On Innovation To Drive Sustained Growth

July, 30, 2014 : Company Profiles and Conferences presents a Company Report on “Veloxis Pharmaceuticals AS (VELO) – Financial and Strategic SWOT Analysis Review”, which helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Veloxis Pharmaceuticals AS (VELO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description A detailed description of the companys operations and business divisions.
– Corporate strategy Analysts summarization of the companys business strategy.
– SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
– Company history Progression of key events associated with the company.
– Major products and services A list of major products, services and brands of the company.
– Key competitors A list of key competitors to the company.
– Key employees A list of the key executives of the company.
– Executive biographies A brief summary of the executives employment history.
– Key operational heads A list of personnel heading key departments/functions.
– Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Veloxis Pharmaceuticals A/S (Veloxis), formerly LifeCycle Pharma A/S, is a specialty pharmaceutical company. It develops therapies based on its proprietary MeltDose reformulation technology platform. The companys products are mainly used for cardiovascular indications and transplant immunosuppression. Veloxiss product portfolio includes Envarsus, LCP-AtorFen and Fenoglide. LCP-FenoChol helps in the treatment of mixed dyslipidemia, hypertriglyceridemia and hypercholesterolemia and is sold under the brand name Fenoglide in the US.

Veloxis Pharmaceuticals AS Key Recent Developments

May 14, 2014: Veloxis Pharmaceuticals announces financial results for the first three months of 2014
Mar 06, 2014: Veloxis Promotes John Weinberg to Chief Operating Officer
Mar 05, 2014: Veloxis Pharmaceuticals publishes Annual Report 2013
Nov 13, 2013: Veloxis Pharmaceuticals announces financial results for the first nine months of 2013 and improves the full year outlook
Aug 21, 2013: Veloxis Pharmaceuticals announces financial results for the first half 2013